Pharmacy Report Archives - Page 66 of 139 - Becker's Hospital Review

What Amylyx's $158K drug could mean for healthcare | Walmart reverses abortion drug policy in NC | Nurse calls 911 over ER crowding | Pharmacist gets prison for $22M fraud scheme | Moderna, Merck partner on cancer vaccine

October 12, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. What Amylyx's $158K ALS drug could mean for healthcare Full story 2. Walmart reverses North Carolina policy that limited drug used for miscarriages Full story 3. Pharmacist gets prison for…

Rite Aid, Google partner | Walgreens to buy CareCentrix for $392M | Providence hospital scales back care | Hourly wage for 25 healthcare jobs: How pharmacists stack up | Whooping cough shot cleared for pregnant people

October 11, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Rite Aid, Google Cloud partner to create the 'modern pharmacy' Full story 2. For $392M, Walgreens to fully acquire CareCentrix Full story 3. Providence hospital scales back care 1 week…

Payers steer members to Mark Cuban's pharmacy | Adderall shortage worsens | Signs of winter COVID surge mount | Medication access disrupted after Ian | Longer Paxlovid course doesn't cut rebound risk: study

October 10, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. How Hurricane Ian's wrath is affecting medication access Full story 2. Payers are steering their members to Mark Cuban's pharmacy Full story 3. Adderall generic shortage worsens to 28 products…

Amylyx defends ALS drug's $158K price tag | Operation Warp Speed has rocky revival | Mayo gives 6% raises | Pa. hospital taps pharmacist for VP role | 10 systems seeking pharmacy leaders

October 6, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. White House plan to revive Operation Warp Speed stumbles Full story 2. Amylyx co-CEOs defend $158K price tag on new ALS drug Full story 3. Tower Health hospital names pharmacist…

HHS to pay 340B hospitals in 2 weeks | Med groups to FDA: Update abortion pill label | Pfizer acquires Biohaven | Epic makes 'significant donation' to UW Health | COVID boosters could prevent 745K admissions

October 5, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. HHS to pay 340B hospitals in 2 weeks after court ruling Full story 2. Medical groups urge FDA to add miscarriage management to abortion pill label Full story 3. 2 Pfizer…

125 drugs in short supply: FDA | CVS chief named most powerful woman in business | Ind. hospital to close | Despite its $3M drugs, Bluebird Bio may not survive | COVID wave is coming: Dr. Eric Topol

October 4, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 125 drugs in short supply, per FDA Full story 2. Fortune names Karen Lynch, CVS Health CEO, most powerful woman in business again Full story 3. Despite its $3M drugs, Bluebird…

Pharmacists can give monkeypox shots: HHS | Walgreens taps robots amid staff shortages | MUSC employee dies in hospital | New ALS drug gets price tag | Rite Aid reports $331M loss

October 3, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Pharmacists can now administer monkeypox vaccine, HHS says Full story 2. Walgreens to use robots for prescription fulfillment amid staff shortages Full story 3. Amylyx's ALS drug will cost $158K for…

HHS to restore full 340B payments this year | 5 most pressing drug shortages | 1 killed in Ark. hospital shooting | What Biogen's Alzheimer's drug win means | 4 potential signs of a fall surge | 10 systems seeking pharmacy leaders

September 29, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Judge orders HHS to restore 340B drug payments after 6-year battle Full story 2. The 5 most pressing drug shortages in the US Full story 3. 4 potential indicators of a…

Bon Secours defends 340B membership amid scrutiny | Alzheimer's drug slowed cognitive decline in key trial | Flu hits Houston Methodist early | J&J spinoff gets name | FDA releases more Moderna boosters amid shortage

September 28, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Biogen's Alzheimer's drug slowed cognitive decline by 27% Full story 2. Bon Secours responds to New York Times article regarding 'profit over patients' Full story 3. J&J names spinoff consumer…

Mark Cuban's pharmacy won't make own PBM | Expand our role, pharmacists tell HHS | Fla. hospitals evacuate as hurricane nears | Court overturns ruling compelling UPMC to give ivermectin | Prescryptive Health buys PBM

September 27, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Mark Cuban's pharmacy teams up with 1st PBM, won't make its own Full story 2. Expand our role, pharmacists tell HHS Full story 3. Prescryptive Health acquires PBM Full story 4. Clinicians…